LYMS:XETRA:XETRA-Amundi Nasdaq-100 II UCITS ETF Acc EUR (EUR)

ETF | Others |

Last Closing

USD 72.49

Change

0.00 (0.00)%

Market Cap

USD 1.23B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-29 )

ETFs Containing LYMS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.87% 82% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.87% 82% B 81% B-
Trailing 12 Months  
Capital Gain 29.17% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.17% 85% B 84% B
Trailing 5 Years  
Capital Gain 160.94% 99% N/A 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 160.94% 99% N/A 97% N/A
Average Annual (5 Year Horizon)  
Capital Gain 21.23% N/A N/A 91% A-
Dividend Return 21.23% N/A N/A 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 21.01% N/A N/A 29% F
Risk Adjusted Return 101.05% N/A N/A 96% N/A
Market Capitalization 1.23B 81% B- 71% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike